A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity

English version České info

The 2009 H1N1 pandemic (H1N1pdm) viruses have evolved to contain an E47K substitution in the HA2 subunit of the stalk region of the hemagglutinin (HA) protein. The biological significance of this single amino acid change was investigated by comparing A/California/7/2009 (HA2-E47) with a later strain, A/Brisbane/10/2010 (HA2-K47). The E47K change was found to reduce the threshold pH for membrane fusion from 5.4 to 5.0. An inter-monomer salt bridge between K47 in HA2 and E21 in HA1, a neighboring highly conserved residue, which stabilized the trimer structure, was found to be responsible for the reduced threshold pH for fusion. The higher structural and acid stability of the HA trimer caused by the E47K change also conferred higher viral thermal stability and infectivity in ferrets, suggesting a fitness advantage for the E47K evolutionary change in humans. Our study indicated that the pH of HA fusion activation is an important factor for influenza virus replication and host adaptation. The identification of this genetic signature in the HA stalk region that influences vaccine virus thermal stability also has significant implications for influenza vaccine production.

Vyšlo v časopise: A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity. PLoS Pathog 10(1): e32767. doi:10.1371/journal.ppat.1003831
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003831

Souhrn

Zdroje

1. GartenRJ, DavisCT, RussellCA, ShuB, LindstromS, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197–201.

2. WHO (2010) WHO global alert and response: pandemic (H1N1) 2009- update 112, weekly update.

3. DawoodFS, IulianoAD, ReedC, MeltzerMI, ShayDK, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12: 687–695.

4. HancockK, VeguillaV, LuX, ZhongW, ButlerEN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945–1952.

5. ChenZ, WangW, ZhouH, SuguitanALJ, ShambaughC, et al. (2010) Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84: 44–51.

6. WangW, SuguitanALJr, ZengelJ, ChenZ, JinH (2012) Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage. Vaccine 30: 872–878.

7. ImaiM, KawaokaY (2012) The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol 2: 160–167.

8. BulloughPA, HughsonFM, SkehelJJ, WileyDC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371: 37–43.

9. DuBoisRM, ZaraketH, ReddivariM, HeathRJ, WhiteSW, et al. (2011) Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathog 7: e1002398.

10. GallowaySE, ReedML, RussellCJ, SteinhauerDA (2013) Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9: e1003151.

11. ImaiM, WatanabeT, HattaM, DasSC, OzawaM, et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420–428.

12. KoernerI, MatrosovichMN, HallerO, StaeheliP, KochsG (2012) Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. J Gen Virol 93: 970–979.

13. ZaraketH, BridgesOA, RussellCJ (2013) The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J Virol 87: 4826–4834.

14. BarrIG, CuiL, KomadinaN, LeeRT, LinRT, et al. (2010) A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill 15: pii: 19692.

15. IkonenN, HaanpaaM, RonkkoE, LyytikainenO, KuusiM, et al. (2009) Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLoS One 5: e13329.

16. MakGC, LeungCK, ChengKC, WongKY, LimW (2011) Evolution of the haemagglutinin gene of the influenza A(H1N1)2009 virus isolated in Hong Kong, 2009–2011. Euro Surveill 16: pii: 19807.

17. Maurer-StrohS, LeeRT, EisenhaberF, CuiL, PhuahSP, et al. (2010) A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr 2: RRN1162.

18. XuR, EkiertDC, KrauseJC, HaiR, CroweJEJ, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357–360.

19. YangH, CarneyP, StevensJ (2010) Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr Mar 22: RRN1152.

20. MurakamiS, HorimotoT, ItoM, TakanoR, KatsuraH, et al. (2011) Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion. J Virol 86: 1405–1410.

21. CarrCM, ChaudhryC, KimPS (1997) Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A 94: 14306–14313.

22. HaywoodAM, BoyerBP (1986) Time and temperature dependence of influenza virus membrane fusion at neutral pH. J Gen Virol 67 (Pt 12) 2813–2817.

23. RuigrokRW, MartinSR, WhartonSA, SkehelJJ, BayleyPM, et al. (1986) Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology 155: 484–497.

24. StrengellM, IkonenN, ZieglerT, JulkunenI (2011) Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. PLoS One 6: e25848.

25. SteinhauerDA, MartínJ, LinYP, WhartonSA, OldstoneMB, et al. (1996) Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc Natl Acad Sci U S A 93: 12873–12878.

26. DanielsRS, DownieJC, HayAJ, KnossowM, SkehelJJ, et al. (1985) Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40: 431–439.

27. GiannecchiniS, CampitelliL, CalzolettiL, De MarcoMA, AzziA, et al. (2006) Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. J Gen Virol 87: 171–175.

28. LinYP, WhartonSA, MartínJ, SkehelJJ, WileyDC, et al. (1997) Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology 233: 402–410.

29. ReedML, BridgesOA, SeilerP, KimJK, YenHL, et al. (2010) The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84: 1527–1535.

30. ReedML, YenHL, DuBoisRM, BridgesOA, SalomonR, et al. (2009) Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J Virol 83: 3568–3580.

31. SteinhauerDA, WhartonSA, SkehelJJ, WileyDC, HayAJ (1991) Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A 88: 11525–11529.

32. KrennBM, EgorovA, Romanovskaya-RomankoE, WolschekM, NakowitschS, et al. (2011) Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS One 6: e18577.

33. FukuyamaS, KawaokaY (2011) The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 23: 481–486.

34. SmeenkCA, BrownEG (1994) The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68: 530–534.

35. SmeenkCA, WrightKE, BurnsBF, ThakerAJ, BrownEG (1996) Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res 44: 79–95.

36. SuguitanALJ, ZengelJR, JacobsonS, GeeS, CetzJ, et al. (2013) Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influenced influenza vaccination in ferrets. Influenza Other Respi Viruses in press.

37. JinH, LuB, ZhouH, MaC, ZhaoJ, et al. (2003) Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306: 18–24.